Hyppigheden af ALT- niveauer efter behandlingsstop i to behandlingsgrupper er yderligere beskrevet i tabel 4 herunder.
The incidence of post-treatment alanine aminotransferase (ALT) flares in the two treatment arms are further described in Table 4 below.